A learning community for advancing patient care
Truveta accelerates clinical research learning into clinical practice. The Truveta Platform enables researchers to easily build on each other’s work across health systems, readily share their data driven questions and answers, and ultimately speed their time to insight.
“Information is key to solving many of the most challenging healthcare problems. With Truveta, we will have a secure, de-identified nationwide data system, representative of diverse populations, helping us get to discovery faster. This will enable us to provide better care to our communities and save lives with data.”
“When we look at vulnerable communities, we clearly know that certain segments of our population suffer from various diseases at higher rates than others. Having access to the kind of data analytics that Truveta will provide will absolutely allow us to understand how to drive improvements in outcomes, and reduce, and ultimately eliminate disparities.”
“It is a crucial time to join Truveta and be part of the solution to leverage our clinical data to advance care for our patients and for patients around the world. By joining Truveta, Saint Luke’s can contribute data for the global good of humanity and discover new insights that will inform critical public health decisions and provide information that will help us better care for our patients.”
Hear from our health system partners
The Truveta platform enables a range of use cases including
Improve patient care
Variation in patient care today is enormous. Truveta offers insights across health conditions, treatments, and outcomes so physicians can learn how to best treat patients and share this knowledge broadly.
Advance health equity
Marginalized communities, and especially communities of color, suffer from various diseases more than other parts of our overall population. Truveta can help improve health equity, fueling understanding and better care for all communities.
Expedite the rare disease diagnostic odyssey
There are nearly 7,000 rare diseases affecting 30 million people in the U.S. Truveta can help inform physicians and families on the best treatment and therapies.